The FDA just approved a new pain medication called Journavx, which promises to treat pain without the risk of developing an addiction. 21 News is joined by Dr. Jianguo Cheng with the Cleveland Clinic ...

A massive stride has been made in the pain medication industry. The U.S. Food and Drug Administration (FDA) announced Thursday its approval of a non-opioid treatment for moderate to severe acute pain ...

A new drug approved Thursday by the FDA offers pain management but is not addictive. Unlike opioids, it treats pain signals ...

Many public health experts warn of the additive qualities of powerful opioid painkillers. One pharmaceutical company is revealing its new pill that it says does away with those dangers.

The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for adults experiencing moderate to severe acute pain. Journavx received FDA ...

Because the drug doesn’t target the brain, it has less potential for addiction. Learn why this could help the opioid crisis.

This new nonaddictive alternative is the first of its kind that interrupts the pain signal before it reaches the brain.

A new non-opioid painkiller, JournaVX, has received approval from the FDA, marking the first new type of pain medication in ...

Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.

The FDA has approved suzetrigine, a new, non-opioid medication for adults with moderate to severe acute pain.

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...

Journavx (suzetrigine) is said to reduce pin by "targeting a pain-signaling pathway involving sodium channels in the ...